Osteoarthritis Therapy Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type, Disease Indication, End User, and Geography

Description

List of Tables

The osteoarthritis therapy market size is projected to grow from US$ 17.36 billion in 2022 to US$ 30.68 billion by 2030; the market is estimated to record a CAGR of 7.4% during 2022-2030. The rising prevalence of osteoarthritis and innovative therapy options reducing dependency on medications are the key factors propelling the osteoarthritis therapy market development. However, product recall hamper the osteoarthritis therapy market growth. Furthermore, more effective treatment options to fuel osteoarthritis therapy acts as a lucrative market trend during the forecast period.

Growth Drivers:

Rising Prevalence of Osteoarthritis Drives Osteoarthritis Therapy Market Growth

Globally, OA affects more than 500 million people, accounting for 7% of the world's population, according to the CDC report. It represents a major cause of long-term disability. Osteoarthritis is more prevalent among athletes and people who sustain joint injury or trauma. Moreover, it is more prevalent among women, accounting for 60% of global osteoarthritis cases.

According to the World Health Organization (WHO) report, osteoarthritis is more prevalent among the older population. Also, OA can affect anyone, but the condition is most commonly observed in adults aged 40 years and above. Also, the WHO report further reveals that about 73% of the population is older than 55 years and living with OA, among which 60% are female. According to the Centers for Disease Control and Prevention (CDC) report, over 32.5 million adults in the US are affected by OA. Thus, with the rising prevalence of OA and, new therapy options, such as biological therapy, are gaining attention worldwide. Platelet-rich plasma (PRP) therapy is one example that has emerged as a promising OA treatment. PRP enhances tissue recovery by catalyzing the body's natural healing and tissue repair processes.

Report Segmentation and Scope:

The osteoarthritis therapy market is segmented into therapy type, disease indication, and end user. Based on therapy type, the market is segmented into Transcutaneous Electrical Nerve Stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy and stromal vascular fraction, prolotherapy, and others. The market is segmented by disease indication into knee osteoarthritis, spine osteoarthritis, foot & ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. In terms of end-users, the market is segmented into hospitals & clinics, specialty clinics, ambulatory surgical centers (ASCs), homecare, and others.

Therapy Type-Based Insights

By therapy type, the osteoarthritis therapy market is segmented as transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma and stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share of the osteoarthritis therapy market by therapy type segment in 2022. The others segment is anticipated to grow at the fastest CAGR of 7.5% during the forecast period. The physical therapy segment held the largest market share of the osteoarthritis therapy market by therapy type segment in 2022. The other segment is anticipated to grow at the fastest CAGR of 7.5% during the forecast period. Physical therapies, such as yoga, help improve physical function in patients affected by knee osteoarthritis. The clinical study reveals that the patients suffering from knee osteoarthritis receiving physical therapy (PT) have gained more quality-adjusted life-years than those receiving glucocorticoid injections. Additionally, physical therapy is clinically more effective than glucocorticoid injection; moreover, it is perceived as a more cost-effective option.

The other segment is estimated to register the highest CAGR for the osteoarthritis therapy market. Another therapy is rehabilitation therapy for osteoarthritis. The rehabilitation program is designed to reduce pain and increase functionality quickly. The rehabilitation's main goal is to relieve knee OA symptoms and slow its progression. The future perspective and rehabilitation include nonpharmacological management of OA followed by exercise, which effectively improves the quality of life, joint function, muscle power, strength, and functional performance. Therefore, modifications in rehabilitation programs will ultimately reduce the patients' osteoarthritis pain, bolstering the osteoarthritis therapy market growth during the forecast period.

Disease Based Insights

The knee osteoarthritis segment held the largest market share of the osteoarthritis therapy market by disease indication segment in 2022, and the same segment is anticipated to grow at the fastest CAGR of 7.7% during the forecast period. According to the National Academy of Science report, knee osteoarthritis (KO) accounts for more than 80% of the total disease burden, affecting nearly 19% of American adults aged 45 years and above annually. Launches of innovative products by manufacturers can help reduce the burden of knee osteoarthritis. In September 2021, Contura International Ltd announced a new product launch, "Arthrosamid," an alternative to current therapy that fulfills an unmet clinical need for a safe, effective, long-acting, and minimally invasive treatment for alleviating pain associated with knee OA. Therefore, the rising prevalence of knee OA and innovative product launches to minimize osteoarthritis pain drive the osteoarthritis therapy market growth.

End User-Based Insights

The homecare segment held the largest market share of the osteoarthritis therapy market by end-user segment in 2022. Additionally, the hospitals & clinics segment is estimated to register the highest CAGR of 7.5% during the forecast period. The first and foremost remedy to overcome arthritis is reducing excess body weight. Additionally, hot and cold therapies can bring back flexibility in stiff joints, which can help reduce joint pain. The use of electric blankets or moist heating pads proves helpful in reducing pain. However, cold treatments such as packs of ice or bags of frozen vegetables can be applied to the affected joints, giving relief. Availability of such treatment options proves to be a successful remedy for managing osteoarthritis at home, which drives the osteoarthritis therapy market growth for the homecare segment.

Regional Analysis:

Based on geography, the global osteoarthritis therapy market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest global osteoarthritis therapy market share. Asia Pacific is expected to register the highest CAGR during 2022-2030. In the North American market, the US accounts for the largest market share of the osteoarthritis therapy market. According to the statistics revealed in the Centers for Disease Control and Prevention (CDC) report, osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million adults in the US. Additionally, the Osteoarthritis (OA) Action Alliance report reveals that the overall economic burden associated with OA in the US is estimated at US$ 136.8 billion annually. Further, the American Roentgen Ray Society ARRS report reveals that the lifetime risk of OA is 50%, and it is estimated that by 2040, ~78 million (26%) adults in the country will have OA.

Further, new product approvals by the manufacturers aiming for non-pharmacology therapy for OA pain influence the osteoarthritis therapy market growth. In June 2021, CyMedica Orthopedics announced receiving FDA approval for the "Intellihab System," a noninvasive modality for knee osteoarthritis pain. The new product launch is a therapeutic and digital-based ecosystem that is designed to treat OA pain with a debilitating osteoarthritis disease. Therefore, new non-pharmacology therapy intended to reduce dependency on therapeutics in OA treatment would fuel the growth of the osteoarthritis therapy market during the forecast period.

Product Code: TIPRE00038936

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 PEST Analysis
4.2 Pipeline Analysis
- 4.2.1 Clinical Trial Pipeline Analysis

5. Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Osteoarthritis Therapy Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Osteoarthritis
- 5.2.2 Innovative Therapy Options Reducing Dependency on Medications
5.3 Market Restraints
- 5.3.1 Product Recall
5.4 Market Opportunities
- 5.4.1 Availability of Regenerative Medicine
5.5 Future Trends
- 5.5.1 More Effective Treatment Options
5.6 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Global Market Analysis

6.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2022-2030
- 6.1.1 Overview
- 6.1.2 Osteoarthritis Therapy Market Revenue (US$ Million), 2022-2030

7. Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
- 7.2.1 Overview
- 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
- 7.3.1 Overview
- 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
- 7.4.1 Overview
- 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
- 7.5.1 Overview
- 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
- 7.6.1 Overview
- 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview
8.2 Knee Osteoarthritis
- 8.2.1 Overview
- 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
- 8.3.1 Overview
- 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
- 8.4.1 Overview
- 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
- 8.5.1 Overview
- 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
- 8.6.1 Overview
- 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
- 9.5.1 Overview
- 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Osteoarthritis Therapy Market - Geographical Analysis

10.1 Overview North America
- 10.1.1 North America Osteoarthritis Therapy Market Overview
- 10.1.2 North America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.2.1 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
  - 10.1.2.2 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
  - 10.1.2.3 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
- 10.1.3 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.1.3.1 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.1.1 Overview
    - 10.1.3.1.2 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.1.3 United States: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.3.1.4 United States: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.3.1.5 United States: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.3.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.2.1 Overview
    - 10.1.3.2.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.2.3 Canada: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.3.2.4 Canada: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.3.2.5 Canada: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.3.3 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.3.1 Overview
    - 10.1.3.3.2 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.3.3 Mexico: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.3.3.4 Mexico: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.3.3.5 Mexico: Osteoarthritis Therapy Market Breakdown, by End User
10.2 Europe
- 10.2.1 Europe Osteoarthritis Therapy Market Overview
- 10.2.2 Europe: Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)
  - 10.2.2.1 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
  - 10.2.2.2 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
  - 10.2.2.3 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
- 10.2.3 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.1.1 Overview
    - 10.2.3.1.2 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.2.3.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.2.1 Overview
    - 10.2.3.2.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.2.3.3 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.3.1 Overview
    - 10.2.3.3.2 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.2.3.4 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.4.1 Overview
    - 10.2.3.4.2 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.2.3.5 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.5.1 Overview
    - 10.2.3.5.2 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.2.3.6 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.6.1 Overview
    - 10.2.3.6.2 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.2.3.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.2.3.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User
10.3 Asia Pacific
- 10.3.1 Asia Pacific Osteoarthritis Therapy Market Overview
- 10.3.2 Asia Pacific: Osteoarthritis Therapy Market
  - 10.3.2.1 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
  - 10.3.2.2 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
  - 10.3.2.3 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
- 10.3.3 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.1.1 Overview
    - 10.3.3.1.2 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.1.3 China: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.1.4 China: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.1.5 China: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.3.3.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.2.1 Overview
    - 10.3.3.2.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.2.3 Japan: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.2.4 Japan: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.2.5 Japan: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.3.3.3 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.3.1 Overview
    - 10.3.3.3.2 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.3.3 India: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.3.4 India: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.3.5 India: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.3.3.4 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.4.1 Overview
    - 10.3.3.4.2 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.4.3 Australia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.4.4 Australia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.4.5 Australia: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.3.3.5 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.5.1 Overview
    - 10.3.3.5.2 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.5.3 South Korea: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.5.4 South Korea: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.5.5 South Korea: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.3.3.6 Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.6.1 Overview
    - 10.3.3.6.2 Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.6.3 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.3.3.6.4 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.3.3.6.5 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by End User
10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Osteoarthritis Therapy Market Overview
- 10.4.2 Middle East and Africa: Osteoarthritis Therapy Market
  - 10.4.2.1 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
  - 10.4.2.2 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
  - 10.4.2.3 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
- 10.4.3 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.1.1 Overview
    - 10.4.3.1.2 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.1.3 South Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.4.3.1.4 South Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.4.3.1.5 South Africa: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.4.3.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.2.1 Overview
    - 10.4.3.2.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.2.3 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.4.3.2.4 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.4.3.2.5 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.4.3.3 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.3.1 Overview
    - 10.4.3.3.2 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.3.3 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.4.3.3.4 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.4.3.3.5 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.4.3.4 Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.4.1 Overview
    - 10.4.3.4.2 Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.4.3 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.4.3.4.4 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.4.3.4.5 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by End User
10.5 South and Central America
- 10.5.1 South and Central America Osteoarthritis Therapy Market Overview
- 10.5.2 South and Central America: Osteoarthritis Therapy Market
  - 10.5.2.1 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
  - 10.5.2.2 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
  - 10.5.2.3 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
- 10.5.3 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.1.1 Overview
    - 10.5.3.1.2 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.1.3 Brazil: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.5.3.1.4 Brazil: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.5.3.1.5 Brazil: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.5.3.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.2.1 Overview
    - 10.5.3.2.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.2.3 Argentina: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.5.3.2.4 Argentina: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.5.3.2.5 Argentina: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.5.3.3 Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.3.1 Overview
    - 10.5.3.3.2 Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.3.3 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.5.3.3.4 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.5.3.3.5 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Global Osteoarthritis Therapy Market
11.3 Organic Developments
- 11.3.1 Overview
11.1 Inorganic Developments
- 11.1.1 Overview

12. Company Profiles

12.1 Vision Quest Industries Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Dr PRP USA LLC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Estar Technologies Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Zimmer Biomet Holdings Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 DePuy Synthes Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Bioventus Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Omron Healthcare Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Exactech Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Medi GmbH & Co KG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Zealmax Innovations Pvt Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners